Baxion
Screening
Tags
Alerts
Theme
Vir Biotechnology, Inc.
VIR
·
NASDAQ
·
$10.05
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/05/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
02/23/26
10-Q
Q3 ended 09/30/25
11/05/25
10-Q
Q2 ended 06/30/25
08/06/25
Disclosures
Filter
8-K
Current report
10/28/26
8-K
Current report
10/14/26
8-K
Current report
10/08/26
8-K
Current report
10/01/26
8-K
Current report
08/05/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
02/26/26
424B5
Prospectus supplement
02/24/26
S-8
Registration of securities for employees
02/23/26
S-8
Registration of securities for employees
02/27/25
S-8
Registration of securities for employees
02/26/24
Proxies
Filter
DEF 14A
Definitive proxy
04/16/26
DEFA14A
Additional proxy materials
04/16/26
DEF 14A
Definitive proxy
04/17/25
DEFA14A
Additional proxy materials
04/17/25
DEFA14A
Additional proxy materials
05/14/24
Ownership
Filter
Form 3
Initial insider ownership
10/28/26
Form 4
Insider transaction
10/28/26
SC 13G/A
Beneficial ownership (amended)
10/27/26
Form 3
Initial insider ownership
10/06/26
144
Proposed sale of securities
09/17/26
Other
Filter
ARS
Annual report to shareholders
04/16/26
ARS
Annual report to shareholders
04/17/25
ARS
Annual report to shareholders
04/19/24
ARS
Annual report to shareholders
04/07/23
EFFECT
Request for effectiveness
07/07/20
Latest Filings
Filter
8-K
Current report
10/28/26
8-K
Current report
10/14/26
8-K
Current report
10/08/26
8-K
Current report
10/01/26
10-Q
Q2 ended 06/30/26
08/05/26
Ownership
Filter
Form 3
Initial insider ownership
10/28/26
Form 4
Insider transaction
10/28/26
SC 13G/A
Beneficial ownership (amended)
10/27/26
Form 3
Initial insider ownership
10/06/26
144
Proposed sale of securities
09/17/26